About Signify Health, Inc. (SGFY) β Dividend Analysis 2026
Signify Health, Inc. operates a healthcare platform that utilizes analytics, technology, and healthcare provider networks in the United States. The company operates through Home & Community Services and Episodes of Care Services segments. The Home & Community Services segment offers health evaluations performed within the patient's home or at a healthcare provider facility primarily to Medicare Advantage health plans; diagnostic screening and other ancillary services; and services to address healthcare concerns related to social determinants of health. The Episodes of Care Services segment provides services to enhance the healthcare delivery through developing and managing episodic payment programs in partnership with healthcare providers under the Bundled Payment for Care Improvement Advanced program with Centers for Medicare and Medicaid Services; and care management services. The company serves health plans, governments, employers, health systems, and physician groups. The company operates in Norwalk, Connecticut, New York, New York, Dallas, Texas, South Dakota, Deerfield, Florida, and Rapid City. Signify Health, Inc. was founded in 2017 and is headquartered in Dallas, Texas.
Is SGFY a good dividend investment in 2026?
SGFY offers a 6.56% forward yield with a 50% payout ratio. Strand Safety Score: 15/100 (Critical Risk). The 5-year dividend CAGR of -50% is modest β investors should weigh current income against growth alternatives.
SGFY DRIP calculator β what's the difference?
With DRIP on a $10,000 investment over 10 years, your SGFY portfolio grows to $10.46M vs $10.24M without reinvestment. This is the compound interest effect in action.
SGFY dividend growth history & forecast
SGFY has grown its dividend by 0% over the last year and -50% annually over 5 years. At this pace, an investor who holds for 10+ years will see their yield on cost grow substantially above the current 6.56%.
FCF ($70M) is below dividends paid ($586M) β risk of cut (FCF: $70M Β· Dividends est.: $586M)
Debt Leverage0.0Γ Debt/EBITDA
0 / 30 pts
0/30
Company not generating EBITDA β debt servicing risk is elevated
Earnings Momentum-0.1B β +0.0B β -0.0B
15 / 30 pts
15/30
Net income grew in the latest year β positive but trend is unconfirmed
OVERALL ASSESSMENT
High risk of dividend cut β weak fundamentals across multiple factors.
STRAND SCORE
15
/100
Strand Safety Scoreβ’ is proprietary to DividendFlow. Inputs: FCF, Debt/EBITDA, Net Income from SEC filings via FMP. Not financial advice. N/A for ETFs, pre-revenue companies, and tickers without income statements.
π SGFY Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold SGFY.
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
π― SGFY Income Goal & Break-Even
Dividend Break-Even
50yr+
Years for dividends to fully repay your SGFY investment of $30.49/share (πΊπΈ US Taxable (15%) Β· 15.00% tax)
$10K invested Β· 10 Years
Dividends earned (DRIP)
$561.45
Lost to inflation (2.8% CPI)
β$2.5K
Real purchasing power gain
$-1910.84
12-month CPI (US BLS via FMP economic-indicators).
How much do I need to invest in SGFY for:
Shares needed
14,118
Capital required
$430,458
Monthly income
$2,000
Based on current dividend of $2.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
π SGFY Dividend Payment Schedule
SGFY pays quarterly β 4 times per year. Next ex-div: TBD.
Jan
Feb
Mar
π°
Apr
May
Jun
π°
Jul
Aug
Sep
π°
Oct
Nov
Dec
π°
10 shares
$4.25 / payment
$17.00 / year after tax
100 shares
$42.50 / payment
$170.00 / year after tax
1,000 shares
$425.00 / payment
$1700.00 / year after tax
π SGFY vs Healthcare Benchmarks
How SGFY compares to typical Healthcare averages.
Benchmark: Healthcare
Dividend Yieldβ²+3.76% vs sectorBetter
SGFY
6.56%
avg
2.80%
5Y Dividend CAGRβΌ-56.80% vs sectorBelow avg
SGFY
-50.00%
avg
6.80%
Payout Ratioβ²-5.00% vs sectorBetter
SGFY
50.00%
avg
55.00%
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for SGFY sourced from FMP /financial-growth endpoint β real data, not estimates.
ποΈ SGFY Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
Insider
Title
Type
Date
Shares
Price
Total Value
Builder Josh
officer: Chief Technology Officer
C-Conversion
2023-03-29
145,011
β
β
Builder Josh
officer: Chief Technology Officer
D-Return
2023-03-29
119,871
$0.01
$1.2K
Builder Josh
officer: Chief Technology Officer
D-Return
2023-03-29
151,584
β
β
Builder Josh
officer: Chief Technology Officer
D-Return
2023-03-29
132,138
$14.19
$1.88M
Builder Josh
officer: Chief Technology Officer
D-Return
2023-03-29
145,011
β
β
Builder Josh
officer: Chief Technology Officer
C-Conversion
2023-03-29
145,011
β
β
Builder Josh
officer: Chief Technology Officer
D-Return
2023-03-29
150,000
$24.00
$3.60M
Armbrester Bradford Kyle
director, officer: Chief Executive Officer
C-Conversion
2023-03-29
3,686,599
β
β
Armbrester Bradford Kyle
director, officer: Chief Executive Officer
D-Return
2023-03-29
348,097
$0.01
$3.5K
Armbrester Bradford Kyle
director, officer: Chief Executive Officer
C-Conversion
2023-03-29
1,260,625
β
β
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
π―
Analyst Price Target
Wall Street consensus
Current Price
$30.49
Analyst Target
$27.33
Upside / Downside
-10.4%
Range
$20.00 β $32.00
π‘ If SGFY reaches the analyst target of $27.33, investors buying today at $30.49 would see an effective yield of 7.32% on shares purchased at target price β vs 6.56% at current price.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
π¬
Financial Health Scores
Altman Z-Score
6.26
β Safe Zone β low bankruptcy risk
Safe: >3.0 Β· Grey: 1.81β3.0 Β· Distress: <1.81
Piotroski F-Score
4/9
β οΈ Moderate fundamentals
Strong: 7β9 Β· Moderate: 4β6 Β· Weak: 0β3
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
π About This Data
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the SGFY dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β